JPS56131516A - Immunochemotherapy, prevention of resistance to drug, and carcinostatic agent - Google Patents

Immunochemotherapy, prevention of resistance to drug, and carcinostatic agent

Info

Publication number
JPS56131516A
JPS56131516A JP3561780A JP3561780A JPS56131516A JP S56131516 A JPS56131516 A JP S56131516A JP 3561780 A JP3561780 A JP 3561780A JP 3561780 A JP3561780 A JP 3561780A JP S56131516 A JPS56131516 A JP S56131516A
Authority
JP
Japan
Prior art keywords
resistance
prevention
drugs
carcinostatic
immunochemotherapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3561780A
Other languages
English (en)
Japanese (ja)
Other versions
JPS639492B2 (enExample
Inventor
Koutaku Hayashi
Atsuko Watanabe
Yasuko Shimane
Mariko Kuwayama
Etsuko Fujioka
Chieko Uchida
Akiko Ono
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP3561780A priority Critical patent/JPS56131516A/ja
Publication of JPS56131516A publication Critical patent/JPS56131516A/ja
Publication of JPS639492B2 publication Critical patent/JPS639492B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP3561780A 1980-03-18 1980-03-18 Immunochemotherapy, prevention of resistance to drug, and carcinostatic agent Granted JPS56131516A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3561780A JPS56131516A (en) 1980-03-18 1980-03-18 Immunochemotherapy, prevention of resistance to drug, and carcinostatic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3561780A JPS56131516A (en) 1980-03-18 1980-03-18 Immunochemotherapy, prevention of resistance to drug, and carcinostatic agent

Publications (2)

Publication Number Publication Date
JPS56131516A true JPS56131516A (en) 1981-10-15
JPS639492B2 JPS639492B2 (enExample) 1988-02-29

Family

ID=12446802

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3561780A Granted JPS56131516A (en) 1980-03-18 1980-03-18 Immunochemotherapy, prevention of resistance to drug, and carcinostatic agent

Country Status (1)

Country Link
JP (1) JPS56131516A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2290235A (en) * 1994-06-07 1995-12-20 William H Waugh Treatment of sickle cell disorders using aromatic urea compounds

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01305193A (ja) * 1988-06-01 1989-12-08 Mitsubishi Electric Corp 流体ポンプ装置

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2290235A (en) * 1994-06-07 1995-12-20 William H Waugh Treatment of sickle cell disorders using aromatic urea compounds
GB2290235B (en) * 1994-06-07 1998-03-25 William H Waugh Treatment of sickle cell disorders using aromatic urea compounds

Also Published As

Publication number Publication date
JPS639492B2 (enExample) 1988-02-29

Similar Documents

Publication Publication Date Title
IT8767796A0 (it) Forma farmaceutica di dosaggio per somministrazione orale con erogazione controllata di un ingrediente attivo
ES8403024A1 (es) Un procedimiento para la fabricacion de un preparado farmaceutico para uso externo, a base de un compuesto no esteroi- dico.
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
IE871981L (en) Programmed release formulation.
NO970068L (no) Inhaleringssammensetning
ES8105292A1 (es) Procedimiento para la obtencion de derivado de la difenilu- rea halogenosustituidos
HU229443B1 (en) Betha-carboline particulate form, pharmaceutical compositions containing it, their preparations and their use
IE34746L (en) 2-(n-allyl-n-arylamino)-imidazolines
ES8307496A1 (es) Procedimiento para la obtencion de una preparacion galenica antagonista al calcio.
MY129946A (en) Compound with gastric acid inhibitory effect and process for its preparation.
GB1487334A (en) Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof
JPS56131516A (en) Immunochemotherapy, prevention of resistance to drug, and carcinostatic agent
WO2002056867A3 (en) Extended release pharmaceutical compositions containing beta-lactam antibiotics
IE37288B1 (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
IE36780L (en) Pharmaceutical preparations
GB1375806A (enExample)
JPS5791914A (en) Peptic unti-ulcer
KR950700063A (ko) 외상후 스트레스 치료제로서의 브로파로민(Brofaromine as an agent for treating post-traumatic stress)
JPS5746916A (en) Antihyperlipemia
JPS5759809A (en) Cardiotonic agent
JPS5634624A (en) Central nervous system depressant
EP0356192A3 (en) Prevention & treatment of liver abscesses in animals
JPS57126422A (en) Stabilizing method of lysozyme pharmaceutical
JPS57112329A (en) Drug against arterioschlerosis comprising 2,3- dihydroxypropyl ester of n-(7-chloro-4-quinolyl) anthranillic acid
IE43848L (en) Pharmaceutical compositions